Advanced Health Intelligence
Open
–
Prev. Close
–
High
–
Low
–
Market Snapshot
$13.47M
-0.8
Advanced Health Intelligence Ltd. engages in the development of a global digital health solution. The company is headquartered in Perth, Western Australia. The company went IPO on 2015-08-17. The company offers cutting-edge, smart-phone-based health risk identification solutions that enable individuals to run their own comprehensive health assessments and risk stratification. Utilizing smartphone sensor technology, individuals can conduct a single scan or a series of scans to identify established risk markers for various health conditions. The resulting data can then be shared with healthcare providers, insurers, employers, and government agencies, facilitating timely triage and appropriate care pathway allocation. Its products include Digital Health Assessment, FaceScan, and BodyScan. Its solutions encompass anthropometric and body composition analysis, predictive modeling of blood biomarkers, cardiovascular risk estimation, facial photoplethysmography, device-derived dermatological image analysis, atrial fibrillation technology, and others.
emptyResult
Advanced Health Intelligence Ltd. engages in the development of a global digital health solution. The company is headquartered in Perth, Western Australia. The company went IPO on 2015-08-17. The company offers cutting-edge, smart-phone-based health risk identification solutions that enable individuals to run their own comprehensive health assessments and risk stratification. Utilizing smartphone sensor technology, individuals can conduct a single scan or a series of scans to identify established risk markers for various health conditions. The resulting data can then be shared with healthcare providers, insurers, employers, and government agencies, facilitating timely triage and appropriate care pathway allocation. Its products include Digital Health Assessment, FaceScan, and BodyScan. Its solutions encompass anthropometric and body composition analysis, predictive modeling of blood biomarkers, cardiovascular risk estimation, facial photoplethysmography, device-derived dermatological image analysis, atrial fibrillation technology, and others.
Recently from Cashu
Couldn't load Cashu news
Something went wrong. Try refreshing the page.